NEW YORK--(BUSINESS WIRE)--Synchron, the brain-computer interface (BCI) company developing endovascular technology to restore functionality in individuals with motor impairment, today announced the ...

The number of people with electrodes in their brains is believed to have more than doubled in the last couple of years.

Synchron, the brain-computer interface company whose Stentrode implant reaches the brain through a blood vessel instead of ...

BUFFALO, N.Y. – Results of the clinical trial that assessed the safety of Synchron’s endovascular brain-computer interface in people with severe paralysis will be presented Sept. 30 at the Congress of ...

- A patient with ALS in the United States is the first person in the world to use Amazon Alexa via an implantable brain computer interface to interact with and control his environment. NEW ...

在游戏《赛博朋克2077》中，角色可以随意拆卸身上的电子义体，将意识与机械无缝融合。而在现实世界里，实现这一场景的核心技术正是脑机接口（Brain-Computer Interface, BCI）。 2026年4月10日，市场监管总局批准发布一批重要国家标准，涉及新兴领域、安全生产等 ...

Apple has worked on a new standard with Synchron on a brain-computer interface that, among other things, aids folks with disabilities, according to the Wall Street Journal. Synchron has made a ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Interim results from the COMMAND study evaluating the ...

AI thrives on data but feeding it the right data is harder than it seems. As enterprises scale their AI initiatives, they face the challenge of managing diverse data pipelines, ensuring proximity to ...

Neurotech company Synchron has been making massive strides over the past couple of years. It's just announced that a trial participant has used its brain-computer interface (BCI) to turn on the lights ...

A new protocol will allow users implanted with Synchron’s brain-computer interface (BCI) device to control iPhone, iPad and Apple Vision Pro directly with their thoughts without the need for physical ...

In an industry-first, the company Synchron and Mount Sinai Hospital in New York have enrolled their first human patient in a U.S. clinical trial called COMMAND to evaluate an endovascular ...